Cargando…
Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
Neoantigens generated by non-synonymous mutations of tumor genes can induce activation of neoantigen-reactive T (NRT) cells which have the ability to resist the growth of tumors expressing specific neoantigens. Immunotherapy based on NRT cells has made preeminent achievements in melanoma and other s...
Autores principales: | Huang, Ruichen, Zhao, Bi, Hu, Shi, Zhang, Qian, Su, Xiaoping, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108522/ https://www.ncbi.nlm.nih.gov/pubmed/37062844 http://dx.doi.org/10.1186/s40364-023-00478-5 |
Ejemplares similares
-
Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
por: Zhu, Yicheng, et al.
Publicado: (2021) -
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020) -
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017) -
Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer
por: Qin, Huan, et al.
Publicado: (2023) -
Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)